News

Noam Alperin, Ph.D.

Research Team Improves Identification of Surgical Candidates for Neurological Disorder

A multidisciplinary group of Miller School of Medicine researchers, collaborating with investigators from the University of Munich and the University of Pittsburgh, has identified 10 complementing morphologic and physiologic measurements that better characterize a neurological disorder known as Chiari Malformation Type I (CMI) and are likely to improve identification of appropriate surgical candidates.

Read more »

Alan Pollack, M.D., Ph.D.

Miller School Researchers Win $3 Million NIH/NCI Grant to Study Prostate Cancer Management

The National Institutes of Health/National Cancer Institute has awarded researchers at the Miller School of Medicine $3 million in funding over five years to explore breakthrough uses of MRI imaging and genetic signatures in managing prostate cancer diagnosis and treatment.

Read more »

From left, Jean Jose, D.O., Lee Kaplan, M.D., and Allan D. Levi, M.D., Ph.D.

Miller/UHealth Team Defines New Surgical Technique for Removing Neuromas

A collaborative report encompassing three Miller School and UHealth departments highlights a new technique for surgically accessing sensory nerves and neuromas. Published online ahead of print in the journal Neurosurgery, the report is the first to illustrate the use of pre-operative ultrasound combined with specialized needle placement to localize the infrapatellar branches of the saphenous nerve.

Read more »

Robert C. Hendel, M.D.

Dr. Robert Hendel Named Interim Chief of Cardiovascular Division

Robert C. Hendel, M.D., professor of medicine and radiology, has been named interim Chief of the Cardiovascular Division at the University of Miami Miller School of Medicine. Before this appointment, he was the Associate Chief of Clinical Cardiology, Director of the Cardiac Care Unit and Director of Cardiac Imaging at the Miller School

Read more »

Noam Alperin, Ph.D.

Researchers Explore Pharmacological Complement to iNPH Brain Shunt Procedures

An interdisciplinary team of researchers from the Miller School and Weill Cornell Medical College has found that a drug commonly given to young, obese females to treat idiopathic intracranial hypertension also has a condition-reversing effect when given to seniors of either gender who have idiopathic normal-pressure hydrocephalus (iNPH), a type of brain malfunction caused by excessive accumulation of cerebrospinal fluid.

Read more »